Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ALBERTO B VASQUEZ

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1881680114
CMS profile
357558
Location
ST PETERSBURG, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$21,766.09

187 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 2 of 4; records 51–100 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ALBERTO B VASQUEZ

NPI 1881680114 · CMS profile ID 357558

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

ST PETERSBURG, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1881680114?year=2019&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ALBERTO B VASQUEZ, NPI 1881680114, CMS profile ID 357558. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1881680114?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). ALBERTO B VASQUEZ, NPI 1881680114, CMS profile ID 357558. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1881680114?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
ALBERTO B VASQUEZ, NPI 1881680114, CMS profile ID 357558, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1881680114?year=2019&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

187 matching records · $21,766.09 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 187 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 187.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Adamas Pharmaceuticals, Inc. $21.0509/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694974397 CMS
Allergan Inc. $12.1009/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671262181 CMS
Avanir Pharmaceuticals, Inc. $15.9109/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 653621545 CMS
Neurocrine Biosciences, Inc. $16.4509/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693171079 CMS
EMD Serono, Inc. $13.0709/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702999637 CMS
Merz North America, Inc. $22.0108/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 689383435 CMS
UCB, Inc. $18.0808/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688317241 CMS
GENZYME CORPORATION $20.8308/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694160359 CMS
Acorda Therapeutics, Inc $23.6708/26/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 633509373 CMS
GENZYME CORPORATION $38.4408/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694160261 CMS
GENZYME CORPORATION $2,561.0008/23/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694160263 CMS
GENZYME CORPORATION $482.8008/23/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694160265 CMS
Novartis Pharmaceuticals Corporation $17.2308/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659961177 CMS
Amgen Inc. $15.8908/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662157653 CMS
Upsher-Smith Laboratories LLC $21.4908/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 679935713 CMS
Biogen, Inc. $22.1408/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660597115 CMS
GENZYME CORPORATION $18.0008/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694118121 CMS
Teva Pharmaceuticals USA, Inc. $15.2308/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697849347 CMS
Bayer HealthCare Pharmaceuticals Inc. $15.5608/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 628461507 CMS
Bausch Health US, LLC $22.6808/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684536061 CMS
Novartis Pharmaceuticals Corporation $18.2408/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659961191 CMS
UCB, Inc. $15.6207/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688294527 CMS
Alexion Pharmaceuticals, Inc. $99.6507/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695552317 CMS
UCB, Inc. $18.4607/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688298337 CMS
Novartis Pharmaceuticals Corporation $19.5107/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659961173 CMS
Supernus Pharmaceuticals, Inc. $13.2607/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702366207 CMS
Lundbeck LLC $24.5307/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684368227 CMS
GENZYME CORPORATION $20.5107/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694108475 CMS
Amgen Inc. $18.9707/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662157651 CMS
Neurocrine Biosciences, Inc. $21.2707/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693171077 CMS
GENZYME CORPORATION $19.8907/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694097757 CMS
Alexion Pharmaceuticals, Inc. $20.8007/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695552259 CMS
Lilly USA, LLC $12.1607/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657658421 CMS
Teva Pharmaceuticals USA, Inc. $14.5507/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697811049 CMS
Allergan Inc. $10.9507/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671262178 CMS
EMD Serono, Inc. $13.3707/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702997773 CMS
Teva Pharmaceuticals USA, Inc. $10.7607/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697717743 CMS
Adamas Pharmaceuticals, Inc. $18.1807/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694974395 CMS
GE HEALTHCARE $26.5807/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698461213 CMS
Lilly USA, LLC $12.7206/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657658945 CMS
Amneal Pharmaceuticals LLC $14.5106/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 692327681 CMS
GENZYME CORPORATION $15.3106/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694043089 CMS
UCB, Inc. $22.7706/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688292349 CMS
Novartis Pharmaceuticals Corporation $14.5406/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659961171 CMS
GENZYME CORPORATION $15.8006/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694069851 CMS
Acorda Therapeutics, Inc $23.9406/19/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 633509371 CMS
Novartis Pharmaceuticals Corporation $21.4906/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659961197 CMS
Supernus Pharmaceuticals, Inc. $15.4506/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702366205 CMS
Allergan Inc. $11.7706/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671262175 CMS
Teva Pharmaceuticals USA, Inc. $12.8106/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697712609 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $21,766.09 187
PY2020 $2,167.26 32
PY2021 $4,597.27 93
PY2022 $3,190.06 160
PY2023 $6,700.13 169
PY2024 $3,642.81 140
PY2025 $9,810.22 159

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $54,718.79 15
PY2024 Principal investigator $31,317.55 13
PY2023 Recipient $355.00 1
PY2023 Principal investigator $89,097.07 19
PY2022 Recipient $450.00 1
PY2022 Principal investigator $108,308.80 10
PY2021 Principal investigator $266,140.33 60
PY2020 Principal investigator $62,507.00 33
PY2019 Principal investigator $252,110.09 104

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

15 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,125.00 12/12/2025 Non-covered Recipient Entity
SUNCOAST NEUROSCIENCE ASSOCIATES INC
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care No dispute reported 06/30/2026 1223289578
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $500.00 12/12/2025 Non-covered Recipient Entity
SUNCOAST NEUROSCIENCE ASSOCIATES INC
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care No dispute reported 06/30/2026 1223289580
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,360.00 12/10/2025 Non-covered Recipient Entity
SUNCOAST NEUROSCIENCE ASSOCIATES INC
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care No dispute reported 06/30/2026 1223289452
Principal investigator 1 Novartis Pharmaceuticals Corporation $30,131.79 10/27/2025 Non-covered Recipient Entity
SUNCOAST NEUROSCIENCES ASSOCIATES
A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Remibrutinib in Patients With Generalized Myasthenia Gravis, Followed by an Open-label Extension Phase No dispute reported 06/30/2026 1190313613
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $300.00 10/13/2025 Non-covered Recipient Entity
SUNCOAST NEUROSCIENCE ASSOCIATES INC
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care No dispute reported 06/30/2026 1223286721
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,100.00 10/13/2025 Non-covered Recipient Entity
SUNCOAST NEUROSCIENCE ASSOCIATES INC
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care No dispute reported 06/30/2026 1223286723
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $8,150.00 10/13/2025 Non-covered Recipient Entity
SUNCOAST NEUROSCIENCE ASSOCIATES INC
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care No dispute reported 06/30/2026 1223286725
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,700.00 10/13/2025 Non-covered Recipient Entity
SUNCOAST NEUROSCIENCE ASSOCIATES INC
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care No dispute reported 06/30/2026 1223286727
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,750.00 10/13/2025 Non-covered Recipient Entity
SUNCOAST NEUROSCIENCE ASSOCIATES INC
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care No dispute reported 06/30/2026 1223286729
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,200.00 10/13/2025 Non-covered Recipient Entity
SUNCOAST NEUROSCIENCE ASSOCIATES INC
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care No dispute reported 06/30/2026 1223286731
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 10/13/2025 Non-covered Recipient Entity
SUNCOAST NEUROSCIENCE ASSOCIATES INC
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care No dispute reported 06/30/2026 1223286733
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $750.00 10/13/2025 Non-covered Recipient Entity
SUNCOAST NEUROSCIENCE ASSOCIATES INC
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care No dispute reported 06/30/2026 1223286737
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $50.00 10/13/2025 Non-covered Recipient Entity
SUNCOAST NEUROSCIENCE ASSOCIATES INC
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care No dispute reported 06/30/2026 1223286739
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $750.00 10/13/2025 Non-covered Recipient Entity
SUNCOAST NEUROSCIENCE ASSOCIATES INC
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care No dispute reported 06/30/2026 1223286741
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $3,852.00 01/29/2025 Non-covered Recipient Entity
Suncoast Neurosciences Associates
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Relapse Prevention Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimers Disease No dispute reported 06/30/2026 1235993425